Literature DB >> 10797422

Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3).

F Petrij1, J C Dorsman, H G Dauwerse, R H Giles, T Peeters, R C Hennekam, M H Breuning, D J Peters.   

Abstract

Rubinstein-Taybi syndrome (RTS) is a multiple congenital anomalies and mental retardation syndrome characterized by facial abnormalities, broad thumbs, and broad big toes. We have shown previously that disruption of the human CREB-binding protein (CBP) gene, either by gross chromosomal rearrangements or by point mutations, leads to RTS. Translocations and inversions involving chromosome band 16p13.3 form the minority of CBP mutations, whereas microdeletions occur more frequently (approximately 10%). Breakpoints of six translocations and inversions in RTS patients described thus far were found clustered in a 13-kb intronic region at the 5' end of the CBP gene and could theoretically only result in proteins containing the extreme N-terminal region of CBP. In contrast, in one patient with a translocation t(2;16)(q36.3;p13.3) we show by using fiber FISH and Southern blot analysis that the chromosome 16 breakpoint lies about 100 kb downstream of this breakpoint cluster. In this patient, Western blot analysis of extracts prepared from lymphoblasts showed both a normal and an abnormal shorter protein lacking the C-terminal domain, indicating expression of both the normal and the mutant allele. The results suggest that the loss of C-terminal domains of CBP is sufficient to cause RTS. Furthermore, these data indicate the potential utility of Western blot analysis as an inexpensive and fast approach for screening RTS mutations. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797422     DOI: 10.1002/(sici)1096-8628(20000501)92:1<47::aid-ajmg8>3.0.co;2-h

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  Balanced translocations in mental retardation.

Authors:  Geert Vandeweyer; R Frank Kooy
Journal:  Hum Genet       Date:  2009-04-05       Impact factor: 4.132

2.  Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome.

Authors:  Neeti Sharma; Avinash M Mali; Sharmila A Bapat
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

3.  A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4.

Authors:  Rusiko Bourtchouladze; Regina Lidge; Ray Catapano; Jennifer Stanley; Scott Gossweiler; Darlene Romashko; Rod Scott; Tim Tully
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

4.  Rubinstein-taybi syndrome: a female patient with a de novo reciprocal translocation t(2; 16)(q36.3; p13.3) and dysgranulopoiesis.

Authors:  Leuridan Cavalcante Torres; Maria de Lourdes Lopes Chauffaille; Thomaz Pileggi Delboni; Thelma Suely Okay; Magda Carneiro-Sampaio; Sofia Sugayama
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 5.  Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function.

Authors:  Ling Wang; Yong Tang; Philip A Cole; Ronen Marmorstein
Journal:  Curr Opin Struct Biol       Date:  2008-10-27       Impact factor: 6.809

Review 6.  Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.

Authors:  Feng Wang; Christopher B Marshall; Mitsuhiko Ikura
Journal:  Cell Mol Life Sci       Date:  2013-01-11       Impact factor: 9.261

7.  Further peer review failures.

Authors:  Horacio Rivera
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Drosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease.

Authors:  Timothy Cutler; Ankita Sarkar; Michael Moran; Andrew Steffensmeier; Oorvashi Roy Puli; Greg Mancini; Meghana Tare; Neha Gogia; Amit Singh
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

9.  First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.

Authors:  María López; Verónica Seidel; Paula Santibáñez; Cristina Cervera-Acedo; Pedro Castro-de Castro; Elena Domínguez-Garrido
Journal:  BMC Med Genet       Date:  2016-12-13       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.